Amble Health and Luma Health are both positioned as GLP-1 weight loss specialists — not broad multi-category telehealth platforms. Both focus on compounded semaglutide and tirzepatide with physician-prescribed protocols and direct-to-patient shipping. The comparison between them is the most nuanced in Luma Health’s peer group, because they’re the most similar type of provider. The differences come down to pricing, pharmacy disclosure approach, and treatment breadth.


At a Glance

Factor
Luma Health
Amble Health
Compounded semaglutide
$90/mo flat
~$199/mo
Compounded tirzepatide
$165/mo flat
~$249/mo
Annual savings (semaglutide)
$1,308/yr
Named pharmacy (pre-enrollment)
✓ VialsRX, public on website
Disclosed at enrollment
Oral GLP-1 option
✓ $100/mo
Available
Women’s HRT & NAD+
✓ $100/mo each
Weight loss focused only
Flat-rate all dose tiers
✓ Yes
Confirm at intake
Weight loss specialist
✓ Primary focus
✓ Primary focus

Pricing

Both providers are specialist-positioned and both are priced below the large multi-category platforms. Luma Health is lower on both primary medications: $90/month vs. Amble’s approximately $199/month for semaglutide, and $165/month vs. approximately $249/month for tirzepatide. The annual difference on semaglutide is $1,308; on tirzepatide, $1,008.

These are meaningfully different numbers for cash-pay patients managing this expense over an 18–24 month treatment course. Both providers are competitive relative to the broad market; Luma Health is the stronger value between the two.


Pharmacy & Disclosure

Luma Health’s VialsRX disclosure is publicly accessible on the website before a patient submits any personal information. Amble Health discloses its pharmacy during the enrollment process rather than on its public site. Both approaches are legitimate; Luma Health’s pre-enrollment disclosure allows more convenient independent verification.


Treatment Breadth

Amble Health focuses exclusively on GLP-1 weight loss. Luma Health offers GLP-1 medications alongside Women’s HRT and NAD+ therapy at the same $100/month price point, creating a metabolic and hormonal health platform for patients who may benefit from multiple treatments simultaneously. For patients who are exploring HRT alongside GLP-1 treatment (particularly perimenopausal patients for whom weight gain has a hormonal component), this breadth at Luma Health’s price point is a meaningful differentiator.


Verdict: Luma Health vs Amble Health

⚖️ ConsumersVerified Assessment

Both are legitimate specialist GLP-1 providers and both are reasonable choices. Luma Health is the stronger value: lower pricing on both primary medications, publicly named pharmacy for pre-enrollment verification, and a broader treatment menu for patients who may want HRT or NAD+ alongside their GLP-1 program.

The case for Amble Health is a tighter specialist focus on weight loss specifically, which may appeal to patients who want the absolute minimum complexity in their program. Evaluate both intake experiences directly before making your final decision.

Start With Luma Health

Compounded semaglutide $90/mo • Tirzepatide $165/mo • HRT & NAD+ available • VialsRX pharmacy, Houston TX

Visit Luma Health →

FAQ

Is Amble Health a good GLP-1 provider?

Amble Health is a legitimate GLP-1 telehealth provider. See the full Amble Health review for our complete coverage. The primary differentiator from Luma Health is pricing and treatment breadth.

What is Amble Health’s compounding pharmacy?

Amble Health uses a licensed compounding pharmacy, disclosed during the enrollment process. Contact Amble Health directly to confirm the specific facility before enrolling if pre-enrollment pharmacy verification is important to you.

⚖️ Compare All GLP-1 Weight Loss Programs

Read verified reviews for every major weight loss telehealth provider on ConsumersVerified.

View Weight Loss Guide →